520 related articles for article (PubMed ID: 16813742)
1. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.
Ness RB; Sibai BM
Am J Obstet Gynecol; 2006 Jul; 195(1):40-9. PubMed ID: 16813742
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
3. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction.
Manten GT; Sikkema MJ; Voorbij HA; Visser GH; Bruinse HW; Franx A
Hypertens Pregnancy; 2007; 26(1):39-50. PubMed ID: 17454217
[TBL] [Abstract][Full Text] [Related]
5. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces.
James JL; Whitley GS; Cartwright JE
J Pathol; 2010 Aug; 221(4):363-78. PubMed ID: 20593492
[TBL] [Abstract][Full Text] [Related]
6. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
[TBL] [Abstract][Full Text] [Related]
7. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.
Kaufmann P; Black S; Huppertz B
Biol Reprod; 2003 Jul; 69(1):1-7. PubMed ID: 12620937
[TBL] [Abstract][Full Text] [Related]
8. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction.
Kadyrov M; Kingdom JC; Huppertz B
Am J Obstet Gynecol; 2006 Feb; 194(2):557-63. PubMed ID: 16458661
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
[TBL] [Abstract][Full Text] [Related]
10. Abnormal endothelium-dependent microvascular dilator reactivity in pregnancies complicated by normotensive intrauterine growth restriction.
Koopmans CM; Blaauw J; van Pampus MG; Rakhorst G; Aarnoudse JG
Am J Obstet Gynecol; 2009 Jan; 200(1):66.e1-6. PubMed ID: 18799154
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
12. Preeclampsia and future cardiovascular risk.
Newstead J; von Dadelszen P; Magee LA
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):283-94. PubMed ID: 17338672
[TBL] [Abstract][Full Text] [Related]
13. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
14. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction.
Robinson WP; Peñaherrera MS; Jiang R; Avila L; Sloan J; McFadden DE; Langlois S; von Dadelszen P
Prenat Diagn; 2010 Jan; 30(1):1-8. PubMed ID: 19918961
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction.
Christians JK; Gruslin A
Prenat Diagn; 2010 Sep; 30(9):815-20. PubMed ID: 20658698
[TBL] [Abstract][Full Text] [Related]
16. Pre-eclampsia: clinical manifestations and molecular mechanisms.
Baumwell S; Karumanchi SA
Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
[TBL] [Abstract][Full Text] [Related]
17. [Preeclampsia as a maternal vascular disease].
Amash A; Huleihel M; Sheiner E; Sapir O; Holcberg G
Harefuah; 2007 Sep; 146(9):707-12, 733. PubMed ID: 17969310
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in preeclampsia.
Roberts JM
Semin Reprod Endocrinol; 1998; 16(1):5-15. PubMed ID: 9654603
[TBL] [Abstract][Full Text] [Related]
19. Latest advances in understanding preeclampsia.
Redman CW; Sargent IL
Science; 2005 Jun; 308(5728):1592-4. PubMed ID: 15947178
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
Parra MC; Lees C; Mann GE; Pearson JD; Nicolaides KH
Am J Obstet Gynecol; 2001 Feb; 184(3):497-502. PubMed ID: 11228509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
